CN112961873B - 一种双酶耦合合成去甲肾上腺素的方法 - Google Patents
一种双酶耦合合成去甲肾上腺素的方法 Download PDFInfo
- Publication number
- CN112961873B CN112961873B CN202110212194.1A CN202110212194A CN112961873B CN 112961873 B CN112961873 B CN 112961873B CN 202110212194 A CN202110212194 A CN 202110212194A CN 112961873 B CN112961873 B CN 112961873B
- Authority
- CN
- China
- Prior art keywords
- tdc
- genetically engineered
- norepinephrine
- pcdf
- pgex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 title claims abstract description 31
- 229960002748 norepinephrine Drugs 0.000 title claims abstract description 31
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 title claims abstract description 31
- 238000000034 method Methods 0.000 title claims abstract description 29
- 230000002194 synthesizing effect Effects 0.000 title claims abstract description 17
- 230000008878 coupling Effects 0.000 title claims abstract description 16
- 238000010168 coupling process Methods 0.000 title claims abstract description 16
- 238000005859 coupling reaction Methods 0.000 title claims abstract description 16
- 102000004190 Enzymes Human genes 0.000 claims abstract description 39
- 108090000790 Enzymes Proteins 0.000 claims abstract description 39
- 241000894006 Bacteria Species 0.000 claims abstract description 37
- IBGBGRVKPALMCQ-UHFFFAOYSA-N 3,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1O IBGBGRVKPALMCQ-UHFFFAOYSA-N 0.000 claims abstract description 26
- 108030001992 L-threonine aldolases Proteins 0.000 claims abstract description 19
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 19
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000007788 liquid Substances 0.000 claims abstract description 15
- PCYGLFXKCBFGPC-UHFFFAOYSA-N 3,4-Dihydroxy hydroxymethyl benzene Natural products OCC1=CC=C(O)C(O)=C1 PCYGLFXKCBFGPC-UHFFFAOYSA-N 0.000 claims abstract description 13
- 108010035075 Tyrosine decarboxylase Proteins 0.000 claims abstract description 13
- 239000000758 substrate Substances 0.000 claims abstract description 10
- 239000004471 Glycine Substances 0.000 claims abstract description 9
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 9
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 claims abstract description 9
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 claims abstract description 9
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229960001327 pyridoxal phosphate Drugs 0.000 claims abstract description 9
- 240000001929 Lactobacillus brevis Species 0.000 claims abstract description 4
- 235000013957 Lactobacillus brevis Nutrition 0.000 claims abstract description 4
- 241000282453 Ursus americanus Species 0.000 claims abstract description 4
- 238000006243 chemical reaction Methods 0.000 claims description 22
- 238000012258 culturing Methods 0.000 claims description 18
- 239000013612 plasmid Substances 0.000 claims description 12
- 102000004169 proteins and genes Human genes 0.000 claims description 12
- 239000007853 buffer solution Substances 0.000 claims description 11
- 238000005457 optimization Methods 0.000 claims description 11
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 10
- 239000000047 product Substances 0.000 claims description 9
- 238000003786 synthesis reaction Methods 0.000 claims description 9
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 6
- 108020004705 Codon Proteins 0.000 claims description 6
- 241000588724 Escherichia coli Species 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 6
- 239000001110 calcium chloride Substances 0.000 claims description 6
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 6
- 239000001963 growth medium Substances 0.000 claims description 6
- 238000006555 catalytic reaction Methods 0.000 claims description 4
- 239000012535 impurity Substances 0.000 claims description 4
- 230000006698 induction Effects 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 2
- 239000007791 liquid phase Substances 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 2
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 2
- 239000000872 buffer Substances 0.000 claims 1
- 230000001131 transforming effect Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- 239000006227 byproduct Substances 0.000 abstract description 2
- 230000007613 environmental effect Effects 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-M 3-carboxy-2,3-dihydroxypropanoate Chemical compound OC(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-M 0.000 description 1
- LNBCGLZYLJMGKP-LUDZCAPTSA-N 4-[(1r)-2-amino-1-hydroxyethyl]benzene-1,2-diol;(2r,3r)-2,3-dihydroxybutanedioic acid;hydrate Chemical compound O.OC(=O)[C@H](O)[C@@H](O)C(O)=O.NC[C@H](O)C1=CC=C(O)C(O)=C1 LNBCGLZYLJMGKP-LUDZCAPTSA-N 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000011861 acute hypotension Diseases 0.000 description 1
- 210000001943 adrenal medulla Anatomy 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229960001695 norepinephrine bitartrate Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/001—Amines; Imines
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/01—Carboxy-lyases (4.1.1)
- C12Y401/01025—Tyrosine decarboxylase (4.1.1.25)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/02—Aldehyde-lyases (4.1.2)
- C12Y401/02005—L-Threonine aldolase (4.1.2.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110212194.1A CN112961873B (zh) | 2021-02-25 | 2021-02-25 | 一种双酶耦合合成去甲肾上腺素的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110212194.1A CN112961873B (zh) | 2021-02-25 | 2021-02-25 | 一种双酶耦合合成去甲肾上腺素的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112961873A CN112961873A (zh) | 2021-06-15 |
CN112961873B true CN112961873B (zh) | 2024-05-17 |
Family
ID=76286130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110212194.1A Active CN112961873B (zh) | 2021-02-25 | 2021-02-25 | 一种双酶耦合合成去甲肾上腺素的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112961873B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115927144A (zh) * | 2022-09-20 | 2023-04-07 | 福建师范大学 | 一种全细胞催化制备肾上腺素的方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101473039A (zh) * | 2006-04-13 | 2009-07-01 | 帝斯曼知识产权资产管理有限公司 | 在苏氨酸醛缩酶和脱羧酶的存在下由甘氨酸和醛出发制备对映异构富集的β-氨基醇的方法 |
CN103421734A (zh) * | 2013-08-22 | 2013-12-04 | 江南大学 | 一种重组酪氨酸脱羧酶的可溶性高表达的方法及该酶的应用 |
CN110592058A (zh) * | 2019-05-30 | 2019-12-20 | 重庆大学 | 苏氨酸醛缩酶、其编码基因和在屈昔多巴生物合成中的应用 |
-
2021
- 2021-02-25 CN CN202110212194.1A patent/CN112961873B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101473039A (zh) * | 2006-04-13 | 2009-07-01 | 帝斯曼知识产权资产管理有限公司 | 在苏氨酸醛缩酶和脱羧酶的存在下由甘氨酸和醛出发制备对映异构富集的β-氨基醇的方法 |
CN103421734A (zh) * | 2013-08-22 | 2013-12-04 | 江南大学 | 一种重组酪氨酸脱羧酶的可溶性高表达的方法及该酶的应用 |
CN110592058A (zh) * | 2019-05-30 | 2019-12-20 | 重庆大学 | 苏氨酸醛缩酶、其编码基因和在屈昔多巴生物合成中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN112961873A (zh) | 2021-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108070581B (zh) | 一种酶活提高的L-天冬氨酸β-脱羧酶突变体及其应用 | |
CN112813013B (zh) | 一种生产羟基酪醇的重组大肠杆菌及其应用 | |
WO2019119614A1 (zh) | 一种双酶偶联全细胞催化马来酸合成l-天冬氨酸的方法 | |
CN112961873B (zh) | 一种双酶耦合合成去甲肾上腺素的方法 | |
CN114196715A (zh) | 一种化学酶法合成假尿苷的方法 | |
CN112662709A (zh) | 一种双酶偶联合成(r)-香茅醇的方法 | |
CN117737149B (zh) | 一种酶催化合成高纯度s-玻色因的方法 | |
CN110229796B (zh) | 酮还原酶突变体及其在制备度洛西汀手性醇中间体及其类似物中的应用 | |
CN112662644B (zh) | 一种甘油磷酸二酯磷酸二酯酶突变体及其应用 | |
WO2024067086A1 (zh) | 一种可以稳定重复用于d-阿洛酮糖转化合成的地衣芽孢杆菌细胞 | |
CN111471736B (zh) | 制备c1,2-位脱氢甾体化合物的方法 | |
CN111172128A (zh) | 一种蔗糖磷酸化酶在制备2-O-α-D-葡萄糖基-L-抗坏血酸中的应用 | |
CN107674889B (zh) | 一种酶反应合成1,2,4-丁三醇的方法 | |
CN112410385B (zh) | 一种细胞色素p450环氧酶及其应用 | |
CN107828752B (zh) | 一种蔗糖淀粉酶、制备方法及在生产α-熊果苷中的应用 | |
CN112662645B (zh) | 一种鞘磷脂酶d突变体及其应用 | |
CN116064445A (zh) | 一种亮氨酸脱氢酶突变体及其在生产l-2-氨基丁酸中的应用 | |
CN110438055B (zh) | 一种含有苯丙酮酸脱羧酶突变体的全细胞催化剂及在生产苯乙醇中的应用 | |
CN112899320A (zh) | 酶法生产dl-酪氨酸的方法及广谱型氨基酸消旋酶、应用 | |
CN102277327B (zh) | 过表达RimL的大肠杆菌及其在制备N-乙酰化胸腺素α中的应用 | |
CN111500549B (zh) | 制备c1,2-位脱氢甾体化合物的酶及其应用 | |
CN114395573B (zh) | 一种利用反乌头酸脱羧酶提高全细胞催化产衣康酸产量的方法 | |
CN115960862B (zh) | 一种角质酶突变体及其在合成1,4-二乙酰哌嗪中的应用 | |
CN114606212B (zh) | 一种圆锥铁线莲来源的香豆素合酶、基因、载体及其应用 | |
CN114908071B (zh) | 一种壳聚糖亲和蛋白、酶的固定化方法及生物材料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Chen Kequan Inventor after: Wang Xin Inventor after: Qiao Rongmei Inventor after: Zhang Kun Inventor after: Feng Jiao Inventor after: Mai Dandan Inventor after: Ma Chen Inventor after: Lu Jiachen Inventor before: Wang Xin Inventor before: Qiao Rongmei Inventor before: Chen Kequan Inventor before: Zhang Kun Inventor before: Feng Jiao Inventor before: Mai Dandan Inventor before: Ma Chen Inventor before: Lu Jiachen |